KT A832
Alternative Names: AAV-IGF1 - Kriya Therapeutics; KT-A832Latest Information Update: 28 Jun 2024
At a glance
- Originator Kriya Therapeutics
- Class Antihyperglycaemics; Gene therapies; Growth factors
- Mechanism of Action Gene transference; Insulin-like growth factor 1 replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Type 1 diabetes mellitus